Alexandra Schaffert

Alexandra Schaffert

Auto-generated profile, based on publicly available information

Alexandra Schaffert

Tampere University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2023 in Environmental Toxicology and Chemistry
Verified
Journal Article
Open access
LLLaura M. Langan
Laura M. Langan
MPMartin Paparella
Martin Paparella
NBNatalie Burden
Natalie Burden
LCLisa Constantine
Lisa Constantine
LMLuigi Margiotta-Casaluci
Luigi Margiotta-Casaluci
TSTiina Sikanen
Tiina Sikanen
In 2012, 20 key questions related to hazard and exposure assessment and environmental and health risks of pharmaceuticals and personal care products in the natural environment were identified. A decade later, this article examines the current level of knowledge around one of the lowest-ranking questions at that time, number 19: “Can nonanimal testing methods be developed that will provide equivalent or better hazard data compared with current in vivo methods?” The inclusion of alternative methods that replace, reduce, or refine animal testing within the regulatory context of risk and hazard assessment of chemicals generally faces many hurdles, although this varies both by organism (human-centric vs. other), sector, and geographical region or country. Focusing on the past 10 years, only works that might reasonably be considered to contribute to advancements in the field of aquatic environmental risk assessment are highlighted. Particular attention is paid to methods of contemporary interest and importance, representing progress in (1) the development of methods which provide equivalent or better data compared with current in vivo methods such as bioaccumulation, (2) weight of evidence, or (3) -omic-based applications. Evolution and convergence of these risk assessment areas offer the basis for fundamental frameshifts in how data are collated and used for the protection of taxa across the breadth of the aquatic environment. Looking to the future, we are at a tipping point, with a need for a global and inclusive approach to establish consensus. Bringing together these methods (both new and old) for regulatory assessment and decision-making will require a concerted effort and orchestration. Environ Toxicol Chem 2024;43:559–574. © 2023 The Authors. Environmental Toxicology and Chemistry published by Wiley Periodicals LLC on behalf of SETAC.

12 November 2025 in Small Methods
Verified
Journal Article
Open access
ASAngela Serra
Angela Serra
MFMichele Fratello
Michele Fratello
GMGiorgia Migliaccio
Giorgia Migliaccio
ELEmanuele Di Lieto
Emanuele Di Lieto
MMMarcella Torres Maia
Marcella Torres Maia
Dario  GrecoDario Greco
Dario Greco
Despite the advent of mechanistic toxicology using omics data to link molecular perturbations with systemic outcomes, regulatory toxicology still lacks the application of mechanism‐anchored metrics from such data. This is partially because traditional gene‐centric analysis often falls short of linking molecular changes to adverse outcomes. To address this gap, BMDx2, an open‐source tool that transforms multi‐dose toxicogenomics datasets into quantitative, mechanistic evidence for human chemical safety assessment is developed. BMDx2 couples benchmark‐dose modeling with Adverse Outcome Pathway (AOP) enrichment to derive transcriptomic‐based points of departure, enabling potency ranking, chemical prioritization, and mechanistically anchored explanations of the effect of chemical exposures. BMDx2 can process a broad range of data, including DNA microarray and RNA sequencing studies. Here, case studies are used to illustrate the versatility of BMDx2 in characterizing the mechanism of action of chemicals. An initial case study on carbon nanotubes exposure applies integrative analysis of transcriptomics and genome‐wide DNA methylation data, uncovering cellular reprogramming processes underlying fibrosis. A second case study on bleomycin exposure demonstrate how transcriptomic data alone can be mapped to fibrosis‐related AOPs in a standardized, regulatory appropriate manner. Together, these examples show how BMDx2 supports the regulatory application of toxicogenomics and accelerates mechanism‐based chemical safety evaluation.

21 November 2024 in Reviews on Environmental Health
Verified
Journal Article
Open access
GDGabriele Donzelli
Gabriele Donzelli
RGRonette Gehring
Ronette Gehring
SMSivakumar Murugadoss
Sivakumar Murugadoss
TRTom Roos
Tom Roos
ASAlexandra Schaffert
Alexandra Schaffert
Nunzia LinzaloneNunzia Linzalone
Nunzia Linzalone
Toxicology and epidemiology are the two traditional public health scientific disciplines which can contribute to investigate harmful health effects of exposure to toxic substances. Several frameworks for integrating different lines of evidence were proposed since 2011, evolving based of the emergence of new methodologies and approaches. Through the comparison of various theoretical frameworks for evidence integration, we examined similarities, differences, strengths, and weaknesses to provide insights into potential directions for future research. We identified several key challenges of the integration approach to be applied to risk assessment. More specifically, collaboration within a multidisciplinary team of scientists, toxicologists, epidemiologists, and risk assessors, is strongly recommended to be aligned with key regulatory objectives and promote a harmonized approach. Moreover, literature search transparency and systematicity have to be ensured by following validated guidelines, developing parallel protocols for collecting epidemiological and toxicological evidence from various sources, including human, animal, and new approach methodologies (NAMs). Also, the adoption of tailored quality assessment tools is essential to grade the certainty in evidence. Lastly, we recommend the use of the Adverse Outcome Pathway framework to provide a structured understanding of toxicity mechanisms and allow the integration of human, animal, and NAMs data within a single framework.

4 April 2024 in Environmental Research
Verified
Journal Article
Open access
CGCornelius Goerdeler
Cornelius Goerdeler
Beatrice EngelmannBeatrice Engelmann
Beatrice Engelmann
AAAlix Sarah Aldehoff
Alix Sarah Aldehoff
ASAlexandra Schaffert
Alexandra Schaffert
MBMatthias Blüher
Matthias Blüher
MBMartin von Bergen
Martin von Bergen
Growing evidence suggests that exposure to certain metabolism-disrupting chemicals (MDCs), such as the phthalate plasticizer DEHP, might promote obesity in humans, contributing to the spread of this global health problem. Due to the restriction on the use of phthalates, there has been a shift to safer declared substitutes, including the plasticizer diisononyl-cyclohexane-1,2-dicarboxylate (DINCH). Notwithstanding, recent studies suggest that the primary metabolite monoisononyl-cyclohexane-1,2-dicarboxylic acid ester (MINCH), induces differentiation of human adipocytes and affects enzyme levels of key metabolic pathways. Given the lack of methods for assessing metabolism-disrupting effects of chemicals on adipose tissue, we used metabolomics to analyze human SGSB cells exposed to DINCH or MINCH. Concentration analysis of DINCH and MINCH revealed that uptake of MINCH in preadipocytes was associated with increased lipid accumulation during adipogenesis. Although we also observed intracellular uptake for DINCH, the solubility of DINCH in cell culture medium was limited, hampering the analysis of possible effects in the μM concentration range. Metabolomics revealed that MINCH induces lipid accumulation similar to peroxisome proliferator-activated receptor gamma (PPARG)-agonist rosiglitazone through upregulation of the pyruvate cycle, which was recently identified as a key driver of de novo lipogenesis. Analysis of the metabolome in the presence of the PPARG-inhibitor GW9662 indicated that the effect of MINCH on metabolism was mediated at least partly by a PPARG-independent mechanism. However, all effects of MINCH were only observed at high concentrations of 10 μM, which are three orders of magnitudes higher than the current concentrations of plasticizers in human serum. Overall, the assessment of the effects of DINCH and MINCH on SGBS cells by metabolomics revealed no adipogenic potential at physiologically relevant concentrations. This finding aligns with previous in vivo studies and supports the potential of our method as a New Approach Method (NAM) for the assessment of adipogenic effects of environmental chemicals.

12 February 2024 in Environmental Research
Verified
Journal Article
Open access
GDGabriele Donzelli
Gabriele Donzelli
FSFrancesco Sera
Francesco Sera
MMMaria Aurora Morales
Maria Aurora Morales
FVFederico Vozzi
Federico Vozzi
TRTom Roos
Tom Roos
Nunzia LinzaloneNunzia Linzalone
Nunzia Linzalone
Exposure to environmental chemicals has been linked to an increased risk of heart failure, but the impact on left ventricular dysfunction (LVD) markers remains uncertain. To establish a foundation of evidence regarding early HF markers and their association with environmental pollutants, a systematic review and meta-analysis was conducted. The search, conducted on October 13th, 2023, encompassed PubMed, Embase, and Web of Science without filters, focusing on observational studies reporting myocardial geometrical, structural, or functional alterations in individuals without a history of heart disease. This included the general adult population, workers, young people, and the elderly. The risk of bias was assessed using the ROBINS-I tool at both study and item levels. The systematic review included 17 studies involving 43.358 individuals exposed to air pollution and 2038 exposed to heavy metals. Approximately 41% of the effect measures of associations reported significant abnormalities in myocardial structure or function. The metanalyses by pollutants categories indicated positive associations between LV systolic and diastolic abnormalities and exposure to PM2.5 [-0.069 (-0.104, -0.033); -0.044 (-0.062, -0.025)] and PM10 [-0.055 (-0.087, -0.022); -0.030 (-0.050, -0.010)] and NO2 [-0.042 (-0.071, -0.013); -0.021 (-0.037, -0.004)], as well as positive associations between lead exposure and LV systolic abnormalities [-0.033 (-0.051, -0.016)]. To strengthen confidence in the findings and improve the attribution of baseline exposures, the authors recommend conducting more longitudinal and case-control studies. These studies should consider co-exposures, account for vulnerable groups, and identify cardiotoxic compounds that may require regulation. When examining the link between myocardial abnormalities and environmental exposure, it is also advisable to explore the supportive use of Adverse Outcome Pathway (AOP) approaches to confirm a causal relationship.

24 December 2025 in bioRxiv
Verified
Preprint
Open access
ASAlexandra Schaffert
Alexandra Schaffert
SMSivakumar Murugadoss
Sivakumar Murugadoss
TRTom Roos
Tom Roos
Nunzia LinzaloneNunzia Linzalone
Nunzia Linzalone
GDGabriele Donzelli
Gabriele Donzelli
PMPAPARELLA MARTIN
PAPARELLA MARTIN
We present a novel Adverse Outcome Pathway (AOP) network for environmental chemical-induced cardiotoxicity using a bottom-up, data-driven AOP development approach. Mechanistic endpoints were systematically extracted from 339 in vitro and in vivo studies, yielding 1,759 Key Event (KE) entries and 4,938 Key Event Relationship (KER) entries, including information on experimental methods, essentiality evidence (intervention experiments demonstrating upstream-downstream dependence), and study metadata. After quality filtering (high risk of bias, confounding cytotoxicity in vitro, excessive toxicity or animal well-being concerns in vivo, and low-frequency observations), 112 unique KEs and 829 unique KERs supported by at least three independent observations were retained for network construction. Network analysis identified oxidative stress and mitochondrial dysfunction as dominant hub processes linking diverse upstream perturbations to downstream cardiomyocyte injury, inflammation, cardiac remodelling (fibrosis and hypertrophy), decreased cardiac contractility, and reduced left ventricular function. Incorporating exposure duration at the KER level enabled time-resolved pathway interpretation and demonstrated that KE timing is relationship-dependent, revealing temporal patterns not apparent when analysing KEs in isolation. This evidence-weighted, time-resolved AOP network can support endpoint prioritisation and exposure-window selection for non-animal method (NAM) test batteries and mechanistically informed cardiotoxicity assessment.